mPEG Estrogen, PEG Estrogen - MW 5000 Da

Cat. No.: M163989
Disponibile su ordine
QUALITÀ & PUREZZA MW 5000 Da
Storage
Room temperature
Shipped In
Normal
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
M163989-100mg
—
2 Disponibile

73,67€

86,69€
Salva 13,02 € (15.02%)
500mg
M163989-500mg
—
2 Disponibile

243,75€

285,40€
Salva 41,65 € (14.59%)
Enter a quantity for the sizes you want to add.

Panoramica

Estrogen PEG derivatives are a class of bioactive steroid PEG conjugates that can be used to for drug discovery or bioassay development. Estrogen, also called oestrogen, is a primary female sex hormone and is responsible for development and regulation of the female reproductive system and secondary sex characteristics. Pegylated estrogen have better water solubility and other enhanced properties. Nanocs can provide other estrogen PEG derivatives based on customer request.

Specifiche

Specifiche e purezza
MW 5000 Da
Condizioni di conservazione di stoccaggio
Room temperature
Spedito in
Normal

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDataOggetto
D1828042D1828042Certificate of AnalysisJan 10, 2024 M163989
Proprietà chimiche e fisiche
SolubilitàYellow solid or viscous liquid depends on molecule weight;Soluble in regular aqeous solution as well as most organic solvents;
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No tested application protocols, dilutions, or positive controls are provided for this SKU. General starting points for small-molecule/ligand screening workflows (research use only):

  • Stock solution

    • Prepare at 10–50 mM in anhydrous DMSO or 10–100 mg/mL in ethanol, as solubility allows. Filter (0.22 µm).
  • Assay dilution

    • Add to assay buffer to reach the desired final concentration, keeping DMSO/EtOH ≤1–2% v/v when possible.
  • Controls

    • Include vehicle controls matching the highest solvent content. If comparing to the parent estrogen, prepare matched stocks under identical conditions.
  • Storage of stocks

    • Aliquot and store protected from light. See Storage & Reconstitution tab for guidance.

Please consult your specific assay SOPs and validate conditions empirically. For batch-specific details (e.g., functional handles), refer to the CoA/Spec Sheet.

Biological Roles

Item-specific biological data are not provided. The following points summarize relevant background for research use of PEG–estrogen constructs (general, literature; no clinical claims).

  • Estrogen motif

    • Estrogens (e.g., estradiol/estrone derivatives) are steroidal ligands that bind nuclear estrogen receptors (ERα/ERβ) and membrane-associated estrogen-responsive proteins in biological systems.
    • Conjugation to PEG modulates physicochemical properties (solubility, aggregation, nonspecific binding) without necessarily preserving native binding; affinity can vary with linker and attachment site.
  • PEG segment

    • Hydrophilic, flexible polyether that reduces protein adsorption and can alter biodistribution and cellular uptake in model systems.
    • PEG length, architecture (linear vs branched), and terminal groups influence steric shielding and hydration.
  • Research implications

    • PEG–estrogen conjugates are used to study ligand–receptor recognition in aqueous media, to create estrogen-functionalized surfaces, and to examine how macromolecular presentation affects signaling readouts in cell-free or cell-based assays.
    • The conjugates can serve as solubility-improved proxies for hydrophobic hormone ligands in biochemical assay development.

Caution: Ligand activity, receptor selectivity, and downstream signaling may differ substantially from the parent estrogen; empirical validation in the intended system is essential.

Buffer Applications

Buffering capacity is not an inherent property of this material; however, successful use in buffered systems depends on dissolution strategy (general guidance):

  • Stock preparation

    • Dissolve at high concentration in DMSO or ethanol. Typical working stocks for screening: 10–50 mM (or as solubility allows). Filter through 0.22 µm.
  • Dilution into buffers

    • Add stock slowly to vigorously stirred buffer (e.g., PBS, HEPES, Tris) to reach final organic content ≤1–5% v/v to maintain clarity.
    • If precipitation occurs, increase temperature slightly, add a small amount of co-solvent, or include 0.01–0.05% nonionic surfactant (e.g., Tween 20). Validate assay compatibility.
  • pH considerations

    • Maintain neutral pH (6.8–7.6) to minimize potential hydrolysis of ester/carbonate linkers (if present). Avoid strong acid/base unless stability is known.
  • Container considerations

    • Use low-binding polypropylene or silanized glass to reduce analyte loss; PEGylation reduces but does not eliminate surface adsorption.
  • Storage of working solutions

    • Prepare fresh when possible. If storing, keep at 2–8°C protected from light; equilibrate to room temperature before use. Discard if turbidity develops.

Note: Exact solubility behavior depends on PEG length and linkage; verify performance in your buffer system.

Green Alternatives

While the core material is a PEGylated conjugate (PEG is generally regarded as low-toxicity and widely used), greener practices mainly concern solvent and process selection.

  • Preferred solvents (greener choices; general)

    • Water or aqueous buffers whenever feasible (dependent on PEG length and solubility).
    • Bio-based ethanol or isopropanol for stock preparation in place of higher-toxicity polar aprotics when compatible with the assay.
    • 2‑MeTHF or CPME can occasionally replace chlorinated solvents in workup or processing of intermediates (upstream synthesis context).
  • Avoid/limit (when possible)

    • High-boiling dipolar aprotics (NMP, DMF) and DCM due to regulatory/safety profiles; prefer DMSO or EtOH when practicable.
  • Process considerations

    • Minimize organic cosolvent fraction in aqueous assays; design for direct dissolution into buffered media when PEG length permits.
    • Employ room-temperature operations and closed vessels to reduce energy use and emissions.
  • Comparison table (general)

    • DMSO: low volatility, good solvency; acceptable but handle with care for skin absorption.
    • Ethanol: renewable, low toxicity; may have solubility limits depending on PEG length.
    • DMF/NMP: excellent solvency; less preferred environmentally; use only if required.

Always confirm that greener substitutions maintain assay fidelity and analyte stability.

Pharmaceutical Uses

No pharmacopeial grade or excipient designation is provided for this SKU; no clinical or therapeutic uses are claimed. For research and formulation-development purposes only.

  • Relevance in formulation research (general, literature)

    • PEGylation is a common strategy to enhance aqueous compatibility, reduce nonspecific binding, and modulate release in prototype delivery systems.
    • PEG–steroid conjugates can be explored as model ligands in nanoparticle, micelle, or hydrogel systems to study loading, release kinetics, and surface presentation.
  • Excipient context

    • PEG itself is widely used as an excipient; however, PEG–ligand conjugates are specialized research reagents and are not interchangeable with standard PEG grades.
  • Analytical development

    • Method development may employ SEC/GPC for polymer metrics, LC–MS/ELSD for conjugate purity, and stability-indicating assays under ICH-like stress conditions (research stage only).
  • Regulatory note

    • Not intended for human or veterinary use. For laboratory research only. If translational work is contemplated, establish full CMC and safety packages independently.

For batch-specific specifications, impurity profiles, and residual solvent data, consult the CoA/Spec Sheet.

Physical Properties

Item-specific specifications are not provided for this SKU; please consult the CoA/Spec Sheet for definitive values.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet. (Note: PEG length strongly influences MW.)
  • Melting/softening point: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (general, literature)
    • High solubility in polar aprotic solvents (DMSO, DMF, NMP) and alcohols (MeOH, EtOH) due to PEG chain.
    • Aqueous solubility increases with PEG chain length; shorter PEGs may require co-solvent.
    • Poor solubility expected in nonpolar hydrocarbons; partial solubility in chlorinated solvents can vary with PEG length.
  • LogP/logD (general, literature): Apparent lipophilicity is reduced vs. the parent estrogen due to PEG; overall amphiphilic behavior.
  • Density, refractive index, pKa, and UV-Vis: Not specified for this item; refer to CoA/Spec Sheet. (Note: PEG contributes a broad n→σ* background; estrogen chromophore typically absorbs in near-UV.)

Notes:

  • Thermal behavior and glass transition can be influenced by PEG MW and linker chemistry.
  • Hygroscopicity: PEG segments can be mildly hygroscopic; store tightly sealed to limit moisture uptake.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

What to expect for PEG–steroid conjugates (general guidance for professional users):

  • Identity and composition

    • Structural confirmation by 1H/13C NMR (steroid signals, PEG methylene envelope), and HRMS/MALDI as appropriate to the MW range.
    • PEG dispersity: mPEG materials present a Poisson-type MW distribution; reported average (Mn/Mw) should be consulted on the CoA.
    • Conjugation ratio: For defined mPEG–estrogen, the product is typically mono-substituted at a designated steroidal position; CoA should specify.
  • Purity assessment (general)

    • HPLC/UPLC (ELSD/UV) for low–mid MW; GPC/SEC for polymeric characterization (Mn, Mw, Đ).
    • Residual solvents, catalyst/metal residues, and free PEG/free estrogen content are commonly monitored; request full specs if critical.
  • Stabilizers/additives

    • Not specified for this item; refer to CoA/Spec Sheet. Note: Most PEG–steroid conjugates do not require antioxidants unless susceptible linkages are present.
  • Documentation

    • For regulated workflows, request a batch-specific CoA including analytical data, storage recommendations, and handling notes.
Reaction and Applications

Manufacturer application field is not specified for this item; below are common research uses of PEG–estrogen conjugates (general, literature), avoiding any clinical claims.

  • Chemical biology and receptor research

    • Ligand presentation in aqueous media for studying estrogen–receptor interactions under reduced hydrophobic aggregation.
    • Surface immobilization (via PEG chain) to create ligand-decorated interfaces for biosensing assays.
  • Materials and delivery research

    • Amphiphilic behavior supports micelle or nanoparticle formation studies, enabling steroid-functional nanostructures for model transport experiments.
    • Incorporation into hydrogels or brushes to probe hormone-mimetic surface properties.
  • Analytical and assay development

    • Use as a solubility-enhanced analog in high-throughput screening, where DMSO stock management and reduced nonspecific binding are advantageous.
    • Potential as a calibration or recovery standard in methods evaluating PEGylated small molecules (general).
  • Synthetic context

    • If the conjugate retains an additional reactive handle (not specified for this SKU), it can serve as a modular building block for further bioconjugation (e.g., click coupling to dyes or affinity tags). Verify functionality on the CoA before planning chemistry.

Notes: Exact use conditions depend on PEG length, linker stability (carbonate/ester/carbamate), and the particular estrogen variant. Validate performance in your assay matrix.

Reaction Conditions

No item-specific reaction conditions apply because the product is supplied as a finished conjugate. If employing it in further coupling steps or immobilizations, consider the following general guidance (literature-based; verify functional handles on the batch CoA):

  • Solvent system

    • Use dry polar aprotic solvents (DMF, DMSO) or alcohols (MeOH/EtOH) for homogeneous coupling; maintain low water content if moisture-sensitive linkers are involved.
  • Typical coupling scenarios (if a handle is present)

    • NHS ester on the conjugate: react with amines in buffered aqueous/DMF (pH 7.5–8.5) for 0.5–2 h at RT.
    • Azide/alkyne: CuAAC in t‑BuOH/H2O (1:1) or DMSO/H2O with Cu(I) catalyst and ligand at RT–40°C, 0.5–4 h.
    • Maleimide: conjugate to thiols in PBS (pH 6.8–7.2), 0.5–2 h at RT.
  • Concentration and time

    • Work at 0.1–10 mM depending on solubility and desired surface/bioconjugation density. Monitor by LC–MS or GPC.
  • Stability considerations

    • Avoid extremes of pH if the steroid–PEG linkage is an ester/carbonate. Protect from prolonged heating.

If no reactive group is present (common for mPEG end-capped systems), the conjugate is best used as-is in physical/biological assays rather than for further covalent chemistry.

Safety and Handling

Item-specific hazard classification is not provided for this SKU. Always consult the product SDS for authoritative safety information.

  • GHS information

    • Signal word, pictograms, H‑statements: Not specified for this item; refer to SDS.
  • General laboratory precautions (best practice)

    • PPE: lab coat, safety glasses, appropriate gloves (e.g., nitrile). Handle in a fume hood when weighing/dissolving.
    • Avoid inhalation of dust/aerosols and contact with skin/eyes. Wash thoroughly after handling.
    • Polymer–small molecule conjugates may generate fine particulates; minimize dust and use anti-static measures when needed.
  • Incompatibilities and stability (general)

    • Avoid strong oxidizers and strong acids/bases that may cleave ester/carbonate/carbamate linkers (if present).
    • Protect solutions from prolonged elevated temperatures. Some PEG–steroid linkages are hydrolytically labile under extreme pH.
  • First aid (overview; defer to SDS)

    • Skin/eye contact: rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation persists.
    • Inhalation: move to fresh air; seek medical attention if symptoms occur.
    • Ingestion: rinse mouth; do not induce vomiting; seek medical advice.
  • Waste

    • Collect organic/polymeric waste according to institutional and regulatory requirements. Do not discharge to drains.
Solvent Selection

This amphiphilic conjugate typically dissolves well in polar organic media; aqueous solubility depends on PEG length and linkage.

  • Polarity profile (general, literature)

    • Hydrophilic PEG tail favors DMSO, DMF, NMP, and lower alcohols.
    • Hydrophobic steroid head may limit solubility in pure water unless PEG chain is sufficiently long.
  • Practical solvent choices

    • Stock solutions: anhydrous DMSO (common for screening libraries), DMF, or ethanol.
    • Aqueous work: dilute DMSO/EtOH stocks into buffered saline; keep final organic content low (e.g., ≤1–5%) to avoid aggregation; add gentle surfactant if needed (e.g., 0.01–0.05% Tween 20; general guidance).
    • For lyophilization and film-casting experiments: tert‑butanol/water or acetonitrile/water can be useful depending on PEG length (general practice).
  • Comparison (general)

    • vs Estrogen (unmodified): PEGylation markedly improves compatibility with polar solvents and can reduce nonspecific adsorption to plastics and glass.
    • vs Free PEG: The steroid moiety can drive micellization or adsorption to hydrophobic surfaces; solvent polarity and ionic strength can modulate behavior.
  • Tips

    • Filter solutions (0.22 µm) to remove particulates.
    • Verify clarity upon dilution; gentle warming or sonication can help dissolution but avoid prolonged heating.
Storage and Reconstitution
  • Storage conditions (item-specific)

    • Storage: Room temperature (per Product Data). Keep tightly capped, desiccated, and protected from light to minimize moisture/oxidative exposure.
    • Shipped: Normal (ambient) per Product Data.
  • Reconstitution (general guidance)

    • Dissolve in anhydrous DMSO, DMF, or ethanol to prepare concentrated stocks. Record exact concentration gravimetrically or by UV if a validated method exists.
    • Filter through a 0.22 µm PTFE or PVDF membrane to remove particulates.
    • For aqueous use, dilute stock slowly into stirred buffer; maintain final organic solvent content as low as feasible to avoid aggregation.
  • Working solution handling

    • Prepare fresh when possible. If storing solutions, keep at 2–8°C, protected from light, and use within a few days. Inspect for haze/precipitate before use.
  • Stability notes

    • Avoid strong acids/bases and prolonged elevated temperatures that could cleave ester/carbonate linkages (if present; confirm linkage type on CoA).
    • Minimize freeze–thaw of solutions by aliquoting. Solid material tolerates ambient storage; nevertheless, control humidity.

For definitive stability, assay compatibility, and shelf-life, consult the batch-specific CoA/Spec Sheet. Research use only.

Structure and Identity

Overview: This listing refers to a polyethylene glycol–modified estrogen (often termed mPEG–estrogen or PEG–estrogen), i.e., a steroidal estrogen core covalently conjugated to a monomethoxy poly(ethylene glycol) chain. Exact structural details (estrogen subtype, PEG length, linker chemistry) are not provided for this SKU.

  • Item-specific identifiers

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general, literature)

    • Estrogen core: tetracyclic steroid framework (cyclopentanoperhydrophenanthrene), typically bearing phenolic A‑ring functionality (e.g., estrone/estradiol analogs).
    • PEG segment: –(CH2–CH2–O)n– chain; “mPEG” indicates a terminal methoxy cap on one PEG end.
    • Conjugation: commonly via carbonate, carbamate, ether, ester, or click-type linkers from the phenolic OH or other derivatized position on the steroid.
    • Overall architecture: amphiphilic macromolecule; hydrophobic steroid headgroup tethered to hydrophilic PEG tail.
  • Stereochemistry (general, literature)

    • Estrogen steroids are polycyclic and chiral; native configurations (e.g., estradiol) contain multiple defined stereocenters. PEG segment is achiral.

2D description (general): Four fused rings of the steroid core with a phenolic/aryl A‑ring; a flexible PEG chain attached through a linker at a designated functional handle on the steroid nucleus.

Synthetic Utility

This product is a preformed mPEG–estrogen conjugate; as such, its primary utility is as a functional amphiphile or ligand probe rather than a general building block. Nevertheless, the following points may be relevant (general, literature):

  • Functional group landscape

    • Estrogen nucleus (multiple stereocenters), typical phenolic A‑ring derivatization point; remaining steroidal positions may be unmodified or protected during synthesis.
    • mPEG terminus is methoxy-capped (nonreactive); additional reactive handles, if any, depend on the linker design (not specified for this SKU).
  • Upstream synthetic strategies (context)

    • Activation of the estrogen phenol as carbonate or via chloroformate chemistry; coupling to amine- or hydroxyl-terminated PEGs to afford carbamate/carbonate/ether linkages.
    • Click approaches (azide–alkyne cycloaddition) when PEG or steroid possesses the complementary handle.
  • Downstream derivatization

    • If a secondary handle is present (e.g., terminal azide/alkyne/amine on a branched PEG), further conjugation to dyes, affinity tags, or surfaces is possible; verify on CoA before planning.
  • Purification/characterization

    • GPC/SEC for dispersity, LC–MS/MALDI for MW confirmation, and NMR for linker/connectivity.

Given the lack of item-specific reactive functionality in the listing, treat this reagent primarily as a ready-to-use amphiphilic conjugate for assay and materials studies.

Target Specificity

Not applicable. This product is not an antibody or affinity reagent with defined biological target specificity provided in the Product Data. Any receptor interactions (e.g., with estrogen receptors) would be context- and construct-dependent and are not specified for this item.

Domande frequenti

How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.